Concepedia

Matthias Rothemund

MR

14

Publications

336

Citations

13

H-Index

2016

Active since

Affiliations

University of Bayreuth(Current)

Laboratoire de Chimie

Czech Academy of Sciences

Universidad de Murcia

Czech Academy of Sciences, Institute of Biophysics

Matthias Rothemund is an author at University of Bayreuth specializing in drug discovery, natural sciences, and medicinal chemistry.

ORCID

Top concepts

Publications per year

2016–2020

14

Publications

14

New naphthopyran analogues of LY290181 as potential tumor vascular-disrupting agents

Florian Schmitt, Madeleine Gold, Matthias Rothemund et al. · European Journal of Medicinal Chemistry · 2018 · 36 citations

, , +7

Novel cis-[(NHC)<sup>1</sup>(NHC)<sup>2</sup>(L)Cl]platinum(<scp>ii</scp>) complexes – synthesis, structures, and anticancer activities

Tobias Rehm, Matthias Rothemund, Julienne K. Muenzner et al. · Dalton Transactions · 2016 · 33 citations

Copper(<scp>ii</scp>) complexes with tridentate Schiff base-like ligands: solid state and solution structures and anticancer activity

Katja Dankhoff, Madeleine Gold, Luisa Kober et al. · Dalton Transactions · 2019 · 32 citations

, , +13

Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure–Activity Relations of New Inhibitors of HDAC and/or Tubulin Function

Florian Schmitt, Lisa Chiara Gosch, Alexandra Dittmer et al. · International Journal of Molecular Sciences · 2019 · 30 citations · Full text

Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes

Ana Zamora, Sergio A. Pérez, Matthias Rothemund et al. · Chemistry - A European Journal · 2017 · 28 citations

Rows per page

1–5 of 14